Interview: Frans Labuschagne – Head of Pharma, Bayer South Africa
The head of pharma for Bayer Southern Africa reveals how South Africa plays a key role in Bayer’s African strategy, with more than 60 percent of the continent’s total sales,…
The Self-Medication Manufacturers’ Association of South Africa (SMASA) was formally formed in mid-1999 to ensure this important sector of the healthcare industry has a voice in discussions, which affect the health market place in South Africa.
SMASA consists of various member companies in the pharmaceutical and broader healthcare industry. The member companies elect representatives to an Executive Committee (EXCO), which meets regularly to discuss and take action on matters relevant to the industry. Kym Hampton is the current Chairperson of SMASA and Nicola Brink is the Executive Director of the Association.
The objectives of the Association are inter-alia to play a role in the promotion and support of legislative matters; to interact with government, other industry associations and statutory councils.
The Association promotes and protects the interests of the Members of the Association, encouraging co-operation between members and dealing with matters that may affect the common interests of members.
SMASA confers with the Government, and its departments, as well as other interested bodies and parties; and collects and disseminates information likely to be of use to members. Over the years SMASA has been involved in commenting on the Medicines Bill, the draft Benchmarking Regulations, the proposed Logistic Fees and Complementary Medicines and Medical Devices Regulations, Food Regulations, the scheduling of medicines and various guidelines for the registration of medicines, etc. In addition various meetings have been held with the Regulatory Authority on the ban of Advertising of Schedule 2 medicines, which remains an ongoing project. We are currently working with the WSMI (World Self-medication Industry) Task Group looking at the restrictions on the advertising of OTC medicines globally. SMASA continue to serve on various industry initiatives and hold two seats on the Industry Task Group (ITG). Other matters close to our heart are the Schedule 0 Exemption and the Consumer Protection Act.
SMASA has embarked on a PR campaign to promote responsible self-care and self-medication. This project each year culminates into International Self-care Day 24/7 on 24 July every year. SMASA is very active in other industry initiatives an example of which is the Codeine Care project which is a project introduced to mitigate the abuse and misuse of codiene and to accurately screen and control the sale of codeine containing OTC products in South Africa at a pharmacy level.
The Association has a Technical Committee looking at technical matters, including guidelines and policy matters from the Medicines Control Council and legislation.
SMASA is a member of the Marketing Code Authority and serves on the technical committee known as CTAC. SMASA has a seat on the board of the Marketing Code Association. In addition to the Association’s involvement in the compilation of Part A of the Code and the proposed Guideline for the Authority, we compiled Part B of the Code with the relevant Guidance Document for the Self-Medication Industry. In addition Nicola Brink serves as panelists to the Marketing Code on SMASA’s behalf.
SMASA is a member of the World Self-Medication Industry (WSMI) and benefits greatly from their activities. WSMI focuses on three core activities – support to emerging markets, and development of the ‘evidence base’ for non-prescription medicines, and collaborating with multi-lateral organizations.
Manufacturers and other organizations engaged in the self-medication manufacturing industry within South Africa are eligible for membership of the Association. Current members include:
Provision is made for a category called Associate Members who can be a person or a company involved in the supply chain between the manufacturer and the consumer or end-user of self-medication or industry consultants.
Associate members include:
Contact
Self-Medication Manufacturers Association of South Africa
Postal Address: P O Box 651573, Benmore, 2010
Tel: +27(0) 82 410 5859
Email: nicola@smasa.cc
Website: www.smasa.cc
Executive Director: Nicola Brink • Chairperson: Kym Hampton
The head of pharma for Bayer Southern Africa reveals how South Africa plays a key role in Bayer’s African strategy, with more than 60 percent of the continent’s total sales,…
The CEO of Pharma Dynamics explains why the company was the perfect match for Lupin, as the fastest growing, and largest independently owned acquirable pharmaceutical business in South Africa, why…
The chairman of PHARMISA reveals how pharmaceuticals has been designated as one of eight priority sectors of South African Government’s Industrial Policy Action Plan (IPAP), how South African life expectancy…
The CEO of Pierre Fabre for South Africa reveals how his focus has been on marketing the company brand locally, why the goal of the company is to develop business…
The EO of SAMED discusses recent regulations surrounding the medical device industry in South Africa, why South Africa remains the hub and the major gateway to Africa for medical devices…
The managing director of UTi Pharma reveals how UTi is no longer just an international forwarding company but covers a broad spectrum of activities; why as global business increases it…
The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical…
The country manager for BMS South Africa talks about the company’s first to market strategy, and how BMS has shifted the treatment paradigm for oncology in South Africa. Through our platform, we introduce the…
Iain Barton reveals how the acquisition of RTT Medical by IHS in 2013 has allowed Imperial to become the biggest pharma supply chain and general logistics services player on the African…
Peter Fuller provides us with an update on the integration of Covidien businesses, and explains how Medtronic is bringing innovation to South African patients and contributing to the improvement of the…
Adv. Leslie Sedibe, CEO of Proudly South African explains how the Proudly South African campaign aims to promote local products and services to ultimately address unemployment, and what his main…
The country president of Novartis South Africa reveals how Novartis has recently moved to new premises, demonstrating a clear commitment to continue investing in the country; why South Africa…
See our Cookie Privacy Policy Here